Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies

By Smugar Steven S.   Schnitzer Thomas J.   Weaver Arthur L.   Rubin Bernard R.   Polis Adam B.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1353-1367

Informa Healthcare

Access to resources Recommend Favorite

Role of aspirin for prevention and treatment of perioperative cardiovascular events

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S297-S303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial

By  

THE PROSTATE, Vol. 75, Iss. 11, 2015-08 ,pp. : 1160-1166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

By  

THE PROSTATE, Vol. 75, Iss. 13, 2015-09 ,pp. : 1403-1418

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 736-743

John Wiley & Sons Inc

Access to resources Recommend Favorite